CINECA IRIS Institutional Research Information System

BELLINI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.781
AS - Asia 7.337
EU - Europa 5.139
SA - Sud America 1.234
AF - Africa 523
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 6
Totale 27.046
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.418
SG - Singapore 2.391
CN - Cina 1.999
IT - Italia 1.849
HK - Hong Kong 1.146
BR - Brasile 1.022
SE - Svezia 662
VN - Vietnam 632
DE - Germania 497
BG - Bulgaria 367
GB - Regno Unito 355
FR - Francia 296
KR - Corea 277
CA - Canada 266
FI - Finlandia 260
RU - Federazione Russa 217
CD - Congo 206
TR - Turchia 190
UA - Ucraina 155
IN - India 149
JP - Giappone 129
AT - Austria 116
CI - Costa d'Avorio 94
BD - Bangladesh 80
AR - Argentina 71
CH - Svizzera 70
NL - Olanda 63
MX - Messico 56
IQ - Iraq 51
PL - Polonia 49
ES - Italia 47
ZA - Sudafrica 41
MA - Marocco 40
ID - Indonesia 37
NG - Nigeria 32
PK - Pakistan 30
BE - Belgio 29
EC - Ecuador 29
CO - Colombia 28
MY - Malesia 28
SA - Arabia Saudita 26
UZ - Uzbekistan 26
AU - Australia 24
SN - Senegal 24
EG - Egitto 21
VE - Venezuela 19
IR - Iran 18
CL - Cile 16
PH - Filippine 16
KE - Kenya 15
PE - Perù 15
PT - Portogallo 15
JO - Giordania 14
PY - Paraguay 14
DZ - Algeria 13
GR - Grecia 13
NO - Norvegia 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
IE - Irlanda 11
TH - Thailandia 11
UY - Uruguay 11
CZ - Repubblica Ceca 10
LT - Lituania 10
JM - Giamaica 9
NP - Nepal 9
LB - Libano 8
PS - Palestinian Territory 8
ET - Etiopia 7
TW - Taiwan 7
AZ - Azerbaigian 6
BO - Bolivia 6
AL - Albania 5
NI - Nicaragua 5
PA - Panama 5
TT - Trinidad e Tobago 5
BJ - Benin 4
DK - Danimarca 4
EU - Europa 4
GA - Gabon 4
HN - Honduras 4
HU - Ungheria 4
KZ - Kazakistan 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
CR - Costa Rica 3
GT - Guatemala 3
KG - Kirghizistan 3
KH - Cambogia 3
MK - Macedonia 3
OM - Oman 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GY - Guiana 2
LY - Libia 2
NZ - Nuova Zelanda 2
Totale 27.019
Salva come PNG Salva come JPEG
Città #
Ashburn 1.539
Singapore 1.284
Hong Kong 1.129
Fairfield 953
San Jose 826
Woodbridge 758
Santa Clara 720
Houston 647
Dallas 642
Ann Arbor 590
Serra 583
Chandler 529
Seattle 414
Shanghai 401
Sofia 364
Hefei 355
Cambridge 349
Wilmington 343
Beijing 325
New York 317
Seoul 267
Boardman 258
Milan 249
Los Angeles 203
Council Bluffs 194
Boulder 190
Jacksonville 183
Ottawa 179
Princeton 173
Lauterbourg 172
Lubumbashi 160
Lawrence 156
Ho Chi Minh City 149
Medford 136
London 133
Tokyo 119
Helsinki 115
Nanjing 105
Florence 104
Hanoi 96
Munich 95
Abidjan 94
São Paulo 93
Des Moines 88
Izmir 85
Vienna 82
Buffalo 81
Dearborn 78
Istanbul 76
Dong Ket 71
Pisa 67
Frankfurt am Main 66
Redondo Beach 58
Bern 56
San Diego 52
Turku 46
Nanchang 42
Rome 40
Lucca 37
Kunming 36
Orem 36
Washington 35
Jüchen 33
Atlanta 32
Belo Horizonte 31
Bremen 31
Lagos 31
Warsaw 30
Nuremberg 28
Ogden 28
Shenyang 28
Brussels 27
Phoenix 27
Toronto 27
Redwood City 25
Rio de Janeiro 25
Tashkent 25
Chicago 24
Dakar 24
Haiphong 24
Casablanca 23
Columbus 23
Montreal 22
Dhaka 21
Tianjin 21
Baghdad 20
Boende 20
Brooklyn 20
Changsha 20
Hyderabad 20
Amsterdam 19
Chennai 19
Da Nang 19
Norwalk 19
Campinas 18
Düsseldorf 18
Johannesburg 18
Hebei 17
Porto Alegre 17
San Francisco 17
Totale 18.714
Salva come PNG Salva come JPEG
Nome #
Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 538
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 298
Management of Chronic constipation in general practice 267
Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests? 260
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy 254
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 239
Lactobacillus Casei DG® in Patients with Irritable Bowel Syndrome: Not Only a Change of the Gut Microbiota. A Pilot Study 235
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 226
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 219
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis 217
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics 210
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 204
Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole 204
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron 199
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique 198
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 196
Famotidine in the short-term treatment of duodenal ulcer and of concomitant peptic lesions : comparison with cimetidina 194
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 193
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn 193
Irritable bowel syndrome and chronic constipation: Fact and fiction 192
Low FODMAP diet: Evidence, doubts, and hopes 191
The general practitioner's approach to irritable bowel syndrome: from intention to practice 190
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? 190
Role of faecal calprotectin as non-invasive marker of intestinal inflammation 189
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 189
Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation 189
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 188
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 181
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 180
Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance 180
Subthreshold psychiatric psychopathology in Functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry? 179
Trauma quality indicators: internationally approved core factors for trauma management quality evaluation 179
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 178
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults 176
Radionuclide evaluation of the lower gastrointestinal tract 175
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis 175
Refractory Gastroesophageal Reflux Disease: A Management Update 175
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 174
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 172
Liver triglyceride accumulation after chronic ethanol administration: a possible protective role of metadoxina and ubiquinon 171
Alcohol and women: a study in high schools 169
Esophageal testing: What we have so far 166
White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths 165
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 163
Chronic constipation diagnosis and treatment evaluation: The "CHRO.CO.DI.T.E." study 163
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits 160
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio 160
Diets including Animal Food Are Associated with Gastroesophageal Reflux Disease 159
A new psychiatric assessment of patients affected with functional gastrointestinal diseases. 159
Exploring the genetics of irritable bowel syndrome: A GWA study in the general population and replication in multinational case-control cohorts 158
Pelvic floor dyssynergia and psychiatric disorders. Does the snake bite its tail? 157
Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study 157
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. 157
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease 156
Evaluation of latent links between irritable bowel syndrome and sleep quality 156
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 156
Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease 155
Alterazioni della motilità colecistica nella distrofia miotonica: valutazione mediante ecotomografia funzionale 155
Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights 154
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 154
Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations 154
Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease 153
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD 153
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 153
Low fermentable oligo-di-and mono-saccharides and polyols (Fodmaps) or gluten free diet: What is best for irritable bowel syndrome? 153
A low-FODMAP diet for irritable bowel syndrome: Some answers to the doubts from a long-term follow-up 153
The Diagnosis and Management of Chronic Constipation in Italy: Results from a Survey Conducted among Italian Gastroenterologists 152
Pelvic floor rehabilitation for defecation disorders 152
High Resolution and High Definition Anorectal Manometry 152
I farmaci citoprotettivi 151
Gallbladder motility following intake of mineral bicarbonate-alkaline water. Ultrasonographic assessement 146
Serum gamma-glutamyl-transpeptidase isoforms in alcoholic liver disease 146
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 146
Neuroendocrine markers and psychological features in patients with irritable bowel syndrome 146
Difficult defecation in constipated patients: Diagnosis by minimally invasive diagnostic tests 145
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn’s Disease: A Prospective Pilot Study 145
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP) 145
Gastrointestinal manifestations in myotonic muscular dystrophy 145
The genetics of human serotonin transporter and irritable bowel syndrome 145
Diagnosi e follow-up ecografici di un ematoma splenico 144
Are PPI responder patients always confirmed as GERD patients? A MII-PH study. 144
Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications 143
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study 143
Can psychiatric evaluation be useful in patients affected with pelvic floor dyssynergia? 143
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study 143
Is a low FODMAP diet dangerous? 143
Is gluten the only culprit for non-celiac gluten/wheat sensitivity? 143
Fecal calprotectin: Current and future perspectives for inflammatory bowel disease treatment 143
Gastric emptying in myotonic dystrophic patients. 141
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases 140
Different perception of chronic constipation between patients and gastroenterologists 139
Double pylorus: report of two cases and review of the literature 138
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab 137
Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS 136
null 136
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement 136
Plecanatide for the treatment of chronic idiopathic constipation in adult patients 136
The general practitioner's management of patients with a new diagnosis of irritable bowel syndrome 135
An extended assessment of bowel habits in a general population 134
The female pelvic floor through midlife and aging. 134
Totale 17.302
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021249 0 0 0 0 0 0 0 0 0 0 0 249
2021/20221.646 19 71 29 96 298 233 77 107 90 50 112 464
2022/20231.989 248 271 182 132 199 256 25 166 334 7 148 21
2023/20241.688 192 132 232 99 205 348 103 53 43 29 70 182
2024/20256.288 144 215 166 361 441 585 467 355 668 839 798 1.249
2025/20268.390 452 1.044 915 836 775 625 1.091 433 739 919 284 277
Totale 27.566